抗生素抗感染药品获得中国专利权。 Recce Pharmaceuticals gains China patent for drugs tackling antibiotic-resistant infections.

雷克斯制药公司在中国获得抗感染药物的专利, 加强了对抗抗生素耐药性感染的打击. Recce Pharmaceuticals received a patent in China for its anti-infective drugs, boosting its fight against antibiotic-resistant infections. 预科治疗学启动了PTX-100的2A阶段试验,这是一种治疗某种淋巴瘤的药物。 Prescient Therapeutics started a Phase 2A trial for PTX-100, a drug treating a type of lymphoma. Imugene任命John Byon博士为首席医疗官,领导其癌症免疫疗法的发展。 Imugene appointed Dr. John Byon as its Chief Medical Officer to lead its cancer immunotherapy development.